COPD management has changed significantly over the past few years, particularly based on a link between inhaled steroids and critical side effects, like thrush and pneumonia, in COPD patients. It’s been difficult to determine which COPD patients would benefit from inhaled steroids.
Solution: 3 Tools from Prescriber’s Letter:
- January 2020 Prescriber’s Letter article: practical advice and details around recent GOLD guidelines that suggest using blood eosinophil count to help determine when to start an inhaled steroid
- Chart: Inhaled Medications for COPD: sort through options indicated for COPD treatment
- Toolbox: Improving COPD Care: practical tips and resources to help prevent and treat COPD exacerbations, plus prevent COPD-related admissions and readmissions
Get practice changing updates like these each month with Prescriber’s Letter.